Patients with Birt-Hogg-Dube syndrome develop a hereditary form of chromophobe nccRCC characterized by the development of tumors with highly active PI3K/mTOR pathways [26]. This evidence concerns the gene MTOR and Birt-Hogg-Dube syndrome.